Evidence map›Paper›PMID 42459335›Full record

ArticleFrontiers in cellular and infection microbiology2026

Distribution of ST116 carbapenem-resistant

Wanxiang Li, Jie Ma, Cong Zhang, Yuhui Wang, Yang Duan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wanxiang Li *Department of Clinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, China.
Jie Ma *Department of Clinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, China.
Cong ZhangDepartment of Clinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, China.
Yuhui WangDepartment of Clinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, China.
Yang DuanDepartment of Clinical Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To characterize a carbapenem-resistant Methods: A carbapenem-resistant Results: WF1033 exhibited an extensively drug-resistant phenotype and harbored three carbapenemase genes, Conclusions: Our findings suggest that ST116 represents a lineage associated with increased carriage of multiple carbapenem resistance genes in CR-CFR. Continuous genomic surveillance is warranted to monitor the dissemination of multidrug-resistant

Indexed as

Bacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCarbapenemsCitrobacter freundiiGenome, BacterialAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialEnterobacteriaceae InfectionsHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPhylogenyPlasmidsUrinary Tract InfectionsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase KPC-2beta-lactamase NDM-1beta-LactamasescarbapenemaseCarbapenemsIMP-8 enzymecarbapenem resistanceCitrobacter freundiigenomic epidemiologyhybrid plasmidST116

Identifiers

PMID42459335
PMCPMC13368652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.